X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (981) 981
Publication (86) 86
Book Chapter (51) 51
Book Review (7) 7
Conference Proceeding (1) 1
Dissertation (1) 1
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (606) 606
hematology (596) 596
index medicus (443) 443
fviii (346) 346
hemophilia (325) 325
blood coagulation factor viii (257) 257
male (249) 249
factor viii - immunology (205) 205
hemophilia a - drug therapy (205) 205
peripheral vascular disease (184) 184
adult (169) 169
hemophilia a (167) 167
factor viii (160) 160
female (160) 160
haemophilia a (160) 160
factor viii - therapeutic use (159) 159
hemophilia a - immunology (158) 158
inhibitors (150) 150
animals (147) 147
middle aged (143) 143
factor viii - genetics (129) 129
hemophilia a - blood (127) 127
factor viii - metabolism (116) 116
hemophilia a - genetics (111) 111
adolescent (110) 110
child (106) 106
von willebrand factor (106) 106
von-willebrand-factor (103) 103
antibodies (99) 99
analysis (95) 95
factor-viii (93) 93
fviii inhibitors (91) 91
hemophilia-a (91) 91
mutation (90) 90
recombinant factor-viii (90) 90
child, preschool (83) 83
mice (83) 83
aged (82) 82
haemophilia (82) 82
factor viii - administration & dosage (79) 79
hemophilia a - therapy (79) 79
coagulation factors (78) 78
therapy (73) 73
factor-ix (72) 72
plasma (72) 72
previously untreated patients (71) 71
factor viii - antagonists & inhibitors (68) 68
young adult (66) 66
fviii inhibitor (65) 65
immune tolerance (65) 65
coagulation (64) 64
inhibitor development (64) 64
factor viii - analysis (63) 63
prophylaxis (62) 62
risk factors (62) 62
infant (61) 61
treatment outcome (61) 61
recombinant proteins - therapeutic use (60) 60
coagulation-factor-viii (59) 59
hemic and lymphatic diseases (58) 58
safety (58) 58
efficacy (56) 56
factor viii - chemistry (56) 56
factor-viii inhibitors (54) 54
hemophilia a - complications (53) 53
hemophilia a - diagnosis (53) 53
autoantibodies - blood (50) 50
congenital, hereditary, and neonatal diseases and abnormalities (50) 50
diagnosis (50) 50
recombinant fviii (50) 50
hemostasis (49) 49
immune tolerance induction (49) 49
inhibitor (49) 49
bleeding (46) 46
gene therapy (46) 46
pharmacokinetics (46) 46
phenotype (45) 45
management (44) 44
thrombin (43) 43
factor viii - pharmacokinetics (42) 42
severe hemophilia-a (42) 42
expression (41) 41
proteins (41) 41
blood coagulation (40) 40
care and treatment (40) 40
risk (40) 40
von willebrand factor - metabolism (40) 40
children (38) 38
hemophilia-a patients (38) 38
surgery (38) 38
von willebrand disease (38) 38
enzyme-linked immunosorbent assay (37) 37
immunogenicity (37) 37
immunology (36) 36
thrombosis (36) 36
binding (35) 35
disease (35) 35
half-life (35) 35
article (33) 33
health aspects (33) 33
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (979) 979
French (11) 11
Japanese (9) 9
German (7) 7
Italian (5) 5
Czech (4) 4
Spanish (4) 4
Chinese (3) 3
Slovak (3) 3
Polish (2) 2
Turkish (2) 2
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Haemophilia, ISSN 1351-8216, 01/2019, Volume 25, Issue 1, pp. e19 - e26
Introduction The monitoring of factor VIII (FVIII) replacement therapy relies on the accurate measurement of FVIII activity over a large concentration range.... 
extended half‐life FVIII | haemophilia A | factor VIII | FVIII one‐stage FVIII assay | parallelism | extended half-life FVIII | FVIII one-stage FVIII assay | PLASMA | HEMATOLOGY | Coagulation factors | Coagulation | Calibration
Journal Article
Haemophilia, ISSN 1351-8216, 03/2016, Volume 22, Issue 2, pp. 308 - 317
Introduction Acquired haemophilia A (AHA) is a rare, often severe, auto‐immune bleeding disorder caused by the development of inhibitory antibodies... 
acquired haemophilia A | bypass agents | FVIII inhibitors | recombinant porcine FVIII | FVIII | Obizur | Bypass agents | Acquired haemophilia A | Recombinant porcine FVIII | Proteins | Thrombin | Blood coagulation factor VIII | Drug approval | Genetically modified organisms | Hemophilia
Journal Article
Hematology, ISSN 1024-5332, 01/2019, Volume 24, Issue 1, pp. 631 - 636
Objectives: Acquired hemophilia A (AHA) is a rare disease resulting from autoantibodies against coagulation factor VIII that leads to spontaneous bleeding.... 
Acquired hemophilia A | immunosuppressive therapy | bleeding | inhibitor | FVIII activity | corticosteroid | diagnosis | cyclophosphamide | PREVENTION | EPISODES | FVIII | HEMATOLOGY | HEMOSTASIS
Journal Article
Journal Article
Thrombosis Research, ISSN 0049-3848, 2019, Volume 181, pp. S60 - S61
ABSTRACTAcquired hemophilia is a rare but severe condition, which is unknown to medical specialties outside hematology. Sudden appearance of antibodies against... 
Hematology, Oncology, and Palliative Medicine | Acquired hemophilia | FVIII inhibitors | FVIII | Coagulation factor VIII | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Viral antibodies | Antibodies | Blood coagulation factors | Immunotherapy | Hemophilia
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 06/2013, Volume 109, Issue 6, pp. 1007 - 1015
The clinical severity in some patients with haemophilia A appears to be unrelated to the levels of factor (F)VIII activity (FVIII:C), but mechanisms are poorly... 
haemophilia A | association | FVIII | clinical phenotype
Journal Article
Xenotransplantation, ISSN 0908-665X, 7/2014, Volume 21, Issue 4, pp. 341 - 352
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2016, Volume 116, Issue S 01, pp. S10 - S17
Journal Article
Therapeutic Advances in Hematology, ISSN 2040-6207, 2/2013, Volume 4, Issue 1, pp. 59 - 72
Factor VIII (FVIII) replacement therapy is the foundation of treatment in hemophilia A and is effective unless a patient develops an alloantibody (inhibitor)... 
hemophilia A | inhibitors | immune tolerance | risk factors | FVIII | FVIII alloantibodies | Reviews
Journal Article